InsidersTradesSigma
Follow the hVIVO plc share price and the full management transaction log of the company, a listed equity based in United Kingdom. Shares are listed on UK GB, under the supervision of RNS (LSE). Market capitalisation: €46.8m. The latest transaction was reported on 24 April 2026 (Sale). Among the most active insiders: Brendan Buckley. All data is openly available.
Analysts rate hVIVO plc Strong Buy (bullish), based on 8 analysts. Average price target: £16.94.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
hVIVO plc is a UK-based company focused on developing treatments for respiratory and infectious diseases. It specializes in clinical trials and human challenge studies.